journal article·2008-03-25

Covalently Dye-Linked, Surface-Controlled, and Bioconjugated Organically Modified Silica Nanoparticles as Targeted Probes for Optical Imaging

Rajiv Kumar, Indrajit Roy, Tymish Y. Ohulchanskyy, Lalit N. Goswami, Adela C. Bonoiu, Earl J. Bergey, Kenneth M. Tramposch, Anirban Maitra, Paras N. Prasad

ACS Nano· Volume 2· Issue 3
Publisher page

Abstract

In this paper we report the synthesis and characterization of organically modified silica (ORMOSIL) nanoparticles, covalently incorporating the fluorophore rhodamine-B, and surface-functionalized with a variety of active groups. The synthesized nanoparticles are of ultralow size (diameter approximately 20 nm), highly monodispersed, stable in aqueous suspension, and retain the optical properties of the incorporated fluorophore. The surface of the nanoparticles can be functionalized with a variety of active groups such as hydroxyl, thiol, amine, and carboxyl. The carboxyl groups on the surface were used to conjugate with various bioactive molecules such as transferrin, as well as monoclonal antibodies such as anti-claudin 4 and anti-mesothelin, for targeted delivery to pancreatic cancer cell lines. In vitro experiments have revealed that the cellular uptake of these bioconjugated (targeted) nanoparticles is significantly higher than that of the nonconjugated ones. The ease of surface functionalization and incorporation of a variety of biotargeting molecules, combined with their observed noncytotoxicity, makes these fluorescent ORMOSIL nanoparticles potential candidates as efficient probes for optical bioimaging, both in vitro and in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Analytical Chemistry and Sensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, State University of New York, Buffalo, New York 14260-3000

Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21231

References (41)

Show source-provided references
1. Brigger I. · Adv. Drug Delivery Rev. · 2002 · 54 · 63110.1016/S0169-409X(02)00044-3 ↗
2. Alivisatos A. P. · Sci. Am. · 2001 · 285 · 6610.1038/scientificamerican0901-66 ↗
3. Akerman M. E. · Proc. Natl. Acad. Sci. U.S.A. · 2002 · 99 · 1261710.1073/pnas.152463399 ↗
4. Douglas S. J. · Crit. Rev. Ther. Drug Carrier Syst. · 1987 · 3 · 233
5. Holm B. A. · Mol. Cryst. Liq. Cryst. · 2002 · 374 · 58910.1080/713738279 ↗
6. Prasad P. N. · 2004
7. Ferrari M. · Nat. Rev. Cancer · 2005 · 5 · 16110.1038/nrc1566 ↗
8. Emerich D. F. · Expert. Opin. Biol. Ther. · 2005 · 5 · 110.1517/14712598.5.1.1 ↗
9. Cheng M. M. C. · Curr. Opin. Chem. Biol. · 2006 · 10 · 1110.1016/j.cbpa.2006.01.006 ↗
10. Brunner T. J. · Environ. Sci. Technol. · 2006 · 40 · 437410.1021/es052069i ↗
11. Ow H. · Nano Lett. · 2005 · 5 · 11310.1021/nl0482478 ↗
12. Zhao X. · J. Am. Chem. Soc. · 2003 · 125 · 1147410.1021/ja0358854 ↗
13. Zhao X. · Proc. Natl. Acad. Sci. U.S.A. · 2004 · 101 · 1502710.1073/pnas.0404806101 ↗
14. Jain T. K. · J. Am. Chem. Soc. · 1998 · 120 · 1109210.1021/ja973849x ↗
15. Cordek J. · Anal. Chem. · 1999 · 71 · 152910.1021/ac980850l ↗
16. Fang X. H. · J. Am. Chem. Soc. · 1999 · 121 · 292110.1021/ja9837809 ↗
17. Huh S. · Chem. Mater. · 2003 · 15 · 424710.1021/cm0210041 ↗
18. Walcarius A. · Chem. Mater. · 2003 · 15 · 216110.1021/cm021310e ↗
19. Cagnol F. · Chem. Commun. · 2004 · 174210.1039/b403753g ↗
20. Han L. · J. Mater. Chem. · 2007 · 17 · 121610.1039/b615209k ↗
21. Sharma P. · Adv. Colloid Interface Sci. · 2006 · 123 · 47110.1016/j.cis.2006.05.026 ↗
22. Santra S. · J. Nanosci. Nanotechnol. · 2005 · 5 · 89910.1166/jnn.2005.146 ↗
23. Santra S. · Chem. Commun. (Cambridge) · 2005 · 25 · 314410.1039/b503234b ↗
24. Bharali D. J. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 1153910.1073/pnas.0504926102 ↗
25. Roy I. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 27910.1073/pnas.0408039101 ↗
26. Roy I. · J. Am. Chem. Soc. · 2003 · 125 · 786010.1021/ja0343095 ↗
27. Das S. · J. Colloid Interface Sci. · 2002 · 252 · 8210.1006/jcis.2002.8404 ↗
28. Davis S. S. · Trends Biotechnol. · 1997 · 15 · 21710.1016/S0167-7799(97)01036-6 ↗
29. Burns A. · Small · 2006 · 2 · 72310.1002/smll.200600017 ↗
30. Jiang W. · Chem. Mater. · 2006 · 18 · 484510.1021/cm061311x ↗
31. McCarthy D. M. · Appl. Immunohistochem. Mol. Morphol. · 2003 · 11 · 23810.1097/00129039-200309000-00006 ↗
32. Jhala N. · Am. J. Clin. Pathol. · 2006 · 126 · 57210.1309/CEV30BE088CBDQD9 ↗
33. Nichols L. S. · Am. J. Clin. Pathol. · 2004 · 121 · 22610.1309/K144PHVDDUPDD401 ↗
34. Lakowicz J. R. · 198310.1007/978-1-4615-7658-7 ↗
35. White C. E. · 1970
36. Sahoo Y. · J. Phys. Chem. B · 2005 · 109 · 387910.1021/jp045402y ↗
37. Ellman G. L. · Arch. Biochem. Biophys. · 1959 · 82 · 7010.1016/0003-9861(59)90090-6 ↗
38. Lai C. Y. · Methods Enzymol. · 1977 · 47 · 23610.1016/0076-6879(77)47028-9 ↗
39. Butterworth M. D. · J. Colloid Interface Sci. · 1995 · 174 · 51010.1006/jcis.1995.1418 ↗
40. Chung T. · Biomaterials · 2007 · 28 · 295910.1016/j.biomaterials.2007.03.006 ↗
41. Qhobosheane M. · Analyst · 2001 · 126 · 127410.1039/b101489g ↗